160 related articles for article (PubMed ID: 37781074)
1. RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer.
Lv SL; Zhou X; Li YJ; Luo LY; Huang DQ
J Cancer; 2023; 14(15):2784-2797. PubMed ID: 37781074
[No Abstract] [Full Text] [Related]
2. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
[TBL] [Abstract][Full Text] [Related]
3. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
4. The RNA-binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA.
Li Y; Wang S; Li G; Gao C; Cui Z; Cong M; Hu J; Zhang M; Jin X; Sun H; Kong D
Cancer Med; 2024 Apr; 13(7):e7129. PubMed ID: 38618967
[TBL] [Abstract][Full Text] [Related]
5. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
7. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway.
Zhang K; Lin G; Nie Z; Jin S; Bing X; Li Z; Li M
Mol Cell Biochem; 2023 Aug; ():. PubMed ID: 37566200
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
Chen Y; Liu Y; Zhou Y; You H
Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
[TBL] [Abstract][Full Text] [Related]
9. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
10. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
[TBL] [Abstract][Full Text] [Related]
11. Expression of RBMS3 in Breast Cancer Progression.
Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
[TBL] [Abstract][Full Text] [Related]
12. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
Yang Y; Quan L; Ling Y
Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
[TBL] [Abstract][Full Text] [Related]
13. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.
Zhang T; Wu Y; Fang Z; Yan Q; Zhang S; Sun R; Khaliq J; Li Y
Am J Cancer Res; 2016; 6(11):2679-2689. PubMed ID: 27904780
[TBL] [Abstract][Full Text] [Related]
14. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
[TBL] [Abstract][Full Text] [Related]
15. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
[TBL] [Abstract][Full Text] [Related]
18. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
20. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
